Psychiatrists in New Hampshire have issued a call for enhanced science-based leadership in health policy. In a statement, Dr. Gillian Sowden, Dr. Dax C. Volle, and Brian Rosen emphasized the importance of clear, evidence-based guidance from public health leaders, particularly from the U.S. Department of Health and Human Services (DHHS). This leadership is crucial for individuals grappling with mental illness, addiction, and other complex health conditions.
The psychiatrists highlighted the ongoing challenges posed by misinformation surrounding mental health treatments and vaccines. They noted that depression and other mental disorders are among the most disabling conditions in the United States, making reliable public health information essential. Despite the overwhelming evidence supporting the safety and efficacy of psychiatric medications, recent discussions have been overshadowed by doubts fueled by misinformation.
According to the psychiatrists, “Psychiatric medications save lives and have overwhelming evidence to demonstrate their safety and effectiveness when prescribed responsibly by trained medical professionals.” Yet, they expressed concern that the persistence of myths, especially the false link between vaccines and autism, is damaging public health. The evidence consistently shows that vaccines do not cause autism, and equating the two perpetuates stigma against those with autism spectrum disorders.
The statement also addressed the rising rates of autism diagnoses, attributing them to increased awareness, enhanced screening processes, and better access to early intervention programs. They warned that failure to counter misinformation could lead to increased vaccine hesitancy, resulting in the resurgence of preventable diseases and adverse impacts on vulnerable populations.
Medicaid and Medicare are lifelines for many residents in New Hampshire, providing critical access to healthcare services. The psychiatrists pointed out that these programs face ongoing threats from budget cuts and eligibility restrictions, which can undermine patient care. Individuals with psychiatric illnesses often navigate significant barriers, and any uncertainty regarding their access to these benefits can exacerbate their challenges.
The psychiatrists called for leadership that prioritizes science, transparency, and the health of individuals. This includes issuing clear public guidance on medications, vaccines, autism, and the advantages of Medicaid and Medicare. They stressed the need to actively combat misinformation and defend the integrity of these essential programs.
Recent attacks on the safety of vaccines and psychiatric medications have eroded public trust in healthcare systems. In this context, the psychiatrists urged both providers and patients to seek information from reputable sources that are dedicated to evidence-based practices. They identified organizations such as the American College of Physicians, the American Association of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Psychiatric Association as reliable, unbiased resources.
At the state level, public health experts are beginning to collaborate on providing evidence-based guidelines concerning public health and vaccines, with initiatives like the West Coast Health Alliance and the Northeast Public Health Collaborative making strides in this area.
As advocates for their patients, the psychiatrists expressed their commitment to continue promoting mental health care across various settings, including clinics, hospitals, schools, and nursing homes. They concluded by appealing to DHHS leadership, policymakers, and professional societies nationwide to fulfill their responsibilities by leading with science, safeguarding the vulnerable, and protecting the future health of all citizens.
